Dissecting the cellular defects that lead to activated PI3K δ Syndrome (APDS)

被引：0
|
作者：
Lau, Anthony [1 ,2 ]
Bier, Julia [1 ,2 ]
Brink, Robert [1 ,2 ]
Tangye, Stuart [1 ,2 ]
Deenick, Elissa [1 ,2 ]
机构：
[1] Garvan Inst Med Res, Immun & Inflammat Theme, Darlinghurst, NSW, Australia
[2] UNSW Sydney, Fac Med & Hlth, Sydney, NSW, Australia
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
B lymphocytes; cell signalling; follicular helper T cells; immunodeficiency;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OP-274
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [1] Infections in activated PI3K delta syndrome (APDS)
    Brodsky, Nina N.
    Lucas, Carrie L.
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2021, 72 : 178 - 189
  • [2] Analysing the cellular mechanisms underlying activated PI3K δ Syndrome (APDS) reveals differences between APDS1 and APDS2
    Deenick, Elissa
    Lau, Anthony
    Nguyen, Tina
    Bier, Julia
    Brink, Robert
    Tangye, Stuart
    [J]. JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [3] Activated PI3K Delta Syndrome (APDS) in Two Peruvian Pediatric Patients
    Toribio-Dionicio, Crhistian
    Cubas-Guzman, Dania
    Cordova-Calderon, Wilmer
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S68 - S69
  • [4] Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency
    Carpier, Jean-Marie
    Lucas, Carrie L.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 8
  • [5] INTUSSCEPTION: A NOVEL PRESENTATION OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE-Δ (PI3KΔ) SYNDROME (APDS)
    Gold, M.
    Chan, D.
    Marchand, B.
    Dzeladini, L.
    King, J.
    Cheung, A.
    Quinn, P.
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 : 28 - 29
  • [6] Activated PI3Kδ syndrome
    Stretton, Owen
    [J]. LANCET HAEMATOLOGY, 2022, 9 (08): : E557 - E557
  • [7] Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review
    Mahnaz Jamee
    Shakiba Moniri
    Majid Zaki-Dizaji
    Peter Olbrich
    Reza Yazdani
    Farhad Jadidi-Niaragh
    Fatemeh Aghamahdi
    Hassan Abolhassani
    Alison M. Condliffe
    Asghar Aghamohammadi
    Gholamreza Azizi
    [J]. Clinical Reviews in Allergy & Immunology, 2020, 59 : 323 - 333
  • [8] Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review
    Jamee, Mahnaz
    Moniri, Shakiba
    Zaki-Dizaji, Majid
    Olbrich, Peter
    Yazdani, Reza
    Jadidi-Niaragh, Farhad
    Aghamahdi, Fatemeh
    Abolhassani, Hassan
    Condliffe, Alison M.
    Aghamohammadi, Asghar
    Azizi, Gholamreza
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2020, 59 (03) : 323 - 333
  • [9] The Treatment of Activated PI3Kδ Syndrome
    Coulter, Tanya I.
    Cant, Andrew J.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [10] Phase 3 Placebo-Controlled, Randomized Clinical Trial Outcomes of PI3K Delta Inhibitor Leniolisib in Patients with Activated PI3K Delta Syndrome (APDS/PASLI)
    Rao, V. Koneti
    Webster, Sharon
    Sediva, Anna
    Plebani, Alessandro
    Schuetz, Catharina
    Shcherbina, Anna
    Conlon, Niall
    Coulter, Tanya
    Dalm, Virgil
    Trizzino, Antonino
    Zharankova, Yulia
    Kulm, Elaine
    Koerholz, Julia
    Lougaris, Vassilios
    Rodina, Yulia
    Kucher, Klaus
    Radford, Kath
    Bradt, Jason
    Uzel, Gulbu
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S4 - S5
12345